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SUMMARY
The cardiarespiratory and analgesic effects of romifidine or xylazine combined with ketamine was investigated in
dogs. Dogs were premedicated with 1.0 mg/kg of methotrimeprazine IV, followed by 0.1 mg/kg of romifidine (n = 8)
or 1.0 mg/kg of xylazine (n = 8) and 15 mg/kg of ketamine 1M, using a double blind randomised designo Dogs of both
groups developed hypothermia, bradycardia, slight hypotension and reduction in respiratory rate and minute volume.
There were rninimal changes in end tidal CO2 and 02 saturation. There were no differences either in time ar between
the groups in pH, Pa0
2
, and blood biochemistry. The reflexes to pain were reduced until 30-45 minutes of anaesthesia
in both groups. Twelve bitches were divided in two groups as above and underwent ovariohysterectomy. Recovery was
longer after romifidine/ketamine when compared to xylazine/ketamine in both snídies. Although these anaesthetic
protocols produced minimal cardiorespiratory changes, the quality of anaesthesia was not ideal for ovariohysterectomy.
UNITERMS: Methotrimeprazine; Xylazine; Ketamine; Dogs.
INTRODUCTION
Qne of the most popular injectable anaesthesia usedfor small animais is the combination of (X-2
adrenoceptor agonists and ketaminev'. Alpha-2
adrenoceptor agonists produce sedation, analgesia and
muscle relaxation-ó". Other effects of (X-2 adrenoceptor
agonists include bradycardia, arhythmia, atrioventricular
block, transitory hypertension, followed by hypotension,
increase of central venous pressure, reduction of systolic
volume and cardiac output, increase of vascular resistance
and respiratory depression, produced by reduction of
respiratory rate and minute volume'>.
Romifidine is a potent and selective (X-2adrenoceptor
agonist that produces similar cardiorespiratory effects to other
drugs of this group. In horses, romifidine produced a longer
sedation than xylazine'. England et al.' compared the effect
of several doses of romifidine in dogs. No difference in
sedation was observed among these doses, but higher doses
produced a more consistent effect.
Ketarnine is a dissociative anaesthetic widely used in
combination with several drugs in dogs. Ketarnine produces
increased motor activity, hyperreflexia and sympathetic
activation", effects which are counterbalanced when this drug
is combined with (X-2adrenoceptor agonists":". However the
use of (X-2 adrenoceptor agonists even combined with
ketamine may produce emesis, increased secretions,
arhythmia and atrioventricular block'. Atropine may be used
to prevent the xylazine-induced salivation, bradycardia and
arhythmia, but intense hypertension produced by the
combination of these two drugs is an undesirable effect".
Phenotyazines are also widely used for premedication of dogs.
These drugs reduce secretion and have an antiemetic and
antiarrhythmic effects. Methotrimeprazine is a typical
phenotyazine, with the advantage of producing a similar
analgesic effect of morphine'.
The aim of this paper was to study the analgesic and
cardiorespiratory effects of dogs premedicated with
methotrimeprazine and anaesthetised with romifidine or
xylazine, combined with ketarnine.
MATERIAL AND METHOD
This paper was divided in two studies. The first study
was carried out without surgery. The cardiopulmonary
effects of the combination of methotrimeprazine, xylazine
and ketamine or methotrimeprazine, romifidine and
93
RESULTS
LUNA, S.P.L.; NOGUEIRA, C.S.; CRUZ, M.L.; MASSONE, F.; CASTRO, G.B. Romifidine or xylazine combined with ketamine in dogs
premedicated with methotrimeprazine. Braz, J. veto Res. animo Sci., São Paulo, v. 37, n. 2, p. 93-98, 2000.
ketamine were investigated. The second study evaluated
the efficacy of these combinations in order to perform
ovariohysterectomy in bitches.
Study 1 - Anaesthesia
Sixteen mongrel adult dogs weighing 10.2 ± 0.7 kg
and from both sexes were used in a double blind randomised
study. They were starved of food for 12 hours and water was
withheld 2 hours before the beginning of the experiment. Dogs
were premedicated with 1 mg/kg of methotrimeprazine a
intravenously. A 20 gauge catheter b was introduced in the
metatarsal artery for collection of arterial blood samples and
measurement of arterial blood gases. Fifieen minutes later dogs
received an injection of 1 mglkg of xylazine- combined with
15 mglkg of ketamine:' (n = 8) or 0.1 mglkg of romifidine '
combined with 15 mglkg of ketarrtine (n = 8) intramuscularly.
Rectal temperature f, heart rate and electrocardiogram g, indirect
mean arterial blood pressure measured in the radial artery h,
respiratory rate, tidal and minute volume iwere measured before
premedication, 15 minutes after premedication, every 15
minutes after romifidine/ketamine administration for 120
minutes. Expired COo and haemoglobin 00 saturation ' and
arterial blood gas analysis, glucose and electrolytes 1 were
measured for 90 minutes only. Analgesia was investigated for
120 minutes, using a forceps elamped at the skin of the
abdominal region elose to the umbilicus, anal sphincter and
interdigital space. Musele relaxation was also investigated for
120 minutes. The nociceptive response was scored as "O"
normal response, "1" reduced response and "2" no response.
All measurements were performed only until 90 minutes afier
xylazine/ketamine.
Quality of recovery, onset of effect (from 0.-2 agonists/
ketamine administration until no response to elamping at
the abdominal region), duration of anaesthesia (time to
reduced response to c1amping at the abdominal region, when
nociceptive response was scored at least "1"), time to the
first movement of the head, time to assume stemal and
standing position were also measured.
Study 2 - Surgery
Twelve bitches from several breeds, ranging from 6 to
120 (40 ± 10) months and weighing between 4 and 25 (10 ±
2) kg underwent ovariohysterectomy using the same protocol
as previously described: methotrirneprazine/xylazine/ketarrtine
"Neozine, Rhodia, Brazil.
b Abbotth-T Plus, Brazil.
"Coopazine, Malli nkrodt Coopers, Brazil.
d Francotar, Francodex, Brazil.
e Sedivet, Boehringer, Brazil.
f Digital thermometer, Becton Dickinson, Brazil.
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(n = 6) and methotrimeprazine/romifidine/ketamine (n = 6).
Quality of recovery, onset of effect, duration of surgery and
anaesthesia, time to assume stemal and standing position and
response to surgical stimulus were measured.
Statistical analysis
Statistical analysis was performed using an Apple
Macintosh Statview software!", Analysis of variance
(ANOVA) for repeated measures were used in each group
for parametric variables to assess changes from control with
time, followed by Dunnett's test when a significant difference
was indicated'. One way ANOVA was used to compare the
groups at each time point followed by Fisher's Paired Least
Square Difference test when appropriate. Degree of analgesia
was assessed using Friedman test in each group to assess
changes from control with time and Mann Whitney test, to
compare the groups at each time point. Differences were
considered significant when p < 0.05. The tables and graphs
are expressed in means ± standard error of means.
Study 1
Time to onset of effect was 6 ± 1 minutes in both
groups, duration of anaesthesia was 52 ± 6 minutes in dogs
treated with methotrimeprazine/xylazine/ketamine and 60
± 14 minutes in dogs treated with methotrimeprazine/
romifidine/ketamine. Time to standing position was 95 ± 6
minutes in dogs treated with methotrimeprazine/xylazine/
ketamine and 132 ± 17 minutes in dogs treated with
methotrimeprazine/romifidine/ketamine (Tab. 1).
Methotrimeprazine/xylazinelketamine
The anal reflex was reduced until 30 minutes and the
cutaneous and interdigital reflexes until 45 minutes afier
administration of xylazine/ketamine (Fig. 1).
Temperature and heart rate decreased from 15 to 90
minutes afier xylazine/ketamine (Tab. 3). Mean arterial blood
pressure and respiratory rate reduced only at 90 minutes of
anaesthesia (Tab. 3 and 4). Tidal and minute volume reduced
afier premedication, remaining below basal values until 60
(tidal volume) and 90 minutes (minute volume) after
administration of xylazine/ketamine (Tab. 4). Pa02 and
g Funbec 4-1 TC/FC, Brazil.
h DX 2710, Dixtal, Brazil.
; Volumeter, Drager, Germany.
j DX 7100 ETCO,/SpO" Dixtal, Brazil.
I Stat Profile Plus 5 BloÕd Gas Analyser, Nova Biomedical, USA.
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Figure 1
Mean and Standard Error Mean of cutaneous, anal and interdigital
reflexes in dogs anaesthetised with methotrimeprazine/xylazine/
ketamine (n=8)-Botucatu-SP, February to May 1996.
* difference from "O" (after methotrimeprazine).
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Figure 2
Mean and Standard Error Mean of cutaneous, anal and interdigitai
reflexes in dogs anaesthetised with methotrimeprazine/romifidine/
ketamine (n = 8) - Botucatu - SP, February to May 1996.
* difference from "O" (after methotrimeprazine).
haemoglobin 02 saturation increased at 75 and 90 minutes
and blood potassium concentration decreased at 15 and 90
minutes (Tab. 3 and 4). There was no difference in pH, PaC02,
expired CO2, osmolality and blood bicarbonate, sodium,
calcium and glucose concentrations (Tab. 3 and 4).
Methotrimeprazine/romifidine/ketamine
The anal, cutaneous and interdigital reflexes were
reduced until 30 minutes after administration of romifidine/
ketamine (Fig. 2).
Temperature and heart rate decreased from 30 and from
75 minutes respectively after administration of romifidine/
ketamine until120 minutes (Tab. 3). Hypotension was observed
only at 120 minutes and respiratory rate reduced from 15 to
30 and from 75 to 120 minutes after administration of
romifidine/ketarnine (Tab. 3 and 4). Minute volume decreased
from 15 to 120 minutes after the administration of romifidine/
ketamine (Tab. 4). Expired CO2 reduced at 75 minutes and
blood potassium concentration reduced from 75 to 90 minutes
after administration of romifidine/ketamine (Tab. 3 and 4).
No difference was observed for pH, Pa02, PaC02, haemoglobin
02 saturation, osmolality and blood bicarbonate, sodium,
calcium and glucose concentrations (Tab. 3 and 4).
One out of eight dogs showed atrioventricular block
from 25 minutes and two from 45 minutes after
administration of romifidine/ketarnine.
Comparison between groups
Sinusal arhythmia was observed in both groups.
Expired CO2 was higher at 45 and 60 minutes in the dogs
treated with romifidine/ketarnine. Haemoglobin 02 saturation
was lower at 90 minutes in the dogs treated with romifidine/
ketamine.
Myoc1onia, shivering and musc1e spasm occurred
during anaesthesia in 8 out of 8 animais treated with
romifidine/ketamine and 5 out of 8 animais treated with
xylazine/ketamine .
Study 2
Time to onset of effect was 5 ± 1 and 3 ± ] minutes in
dogs treated with methotrimeprazine/xylazine/ketamine and
methotrimeprazinelromifidi ne/ketamine res pecti vely.
Duration of anaesthesia was 59 ± 5 minutes in dogs treated
with methotrimeprazine/xylazine/ketamine and 64 ± 6
minutes in dogs treated with methotrimeprazine/romifidine/
ketarnine. Time to standing position was 162 ± 30 in dogs
treated with methotrimeprazine/xylazine/ketarnine and 222
± 26 in dogs treated with methotrimeprazine/romifidine/
ketarnine (Tab. 2). Time to assume stemal and standing
position was longer in this study when compared with the
same anaesthetic protocol in study 1.
Intense bleeding and tension at the ovarian pedic1e
was observed in three dogs treated with xylazine/ketamine.
Two of these dogs needed local anaesthesia at the ovarian
pedicle, followed in one of them by more 0.5 mg/kg ofxy lazine
and 7.5 mg/kg of ketamine at 30 minutes during anaesthesia.
One dog from the romifidine/ketarnine group showed
muscle hypertonia, movement of the head, neck and lirnbs at
35 minutes during anaesthesia and received another dose of
0.05 mg/kg of romifidine and 7.5 mg/kg ofketamine. No other
reaction was observed thereafter. This animal did not show a
good abdominal muscle relaxation. Bleeding and tension of
the ovarian pedicle was observed in this animal and in other
two dogs from this group.
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Table 1
Mean and Standard Error Mean (minutes) of onset of action, duration
of anaesthesia, time to the first movement of the head and time to
assume sternal and standing position of dogs anaesthetised with
methotrimeprazine/xylazine/ ketamine and methotrimeprazine/
romifidinelketamine. There was no significant difference between
the groups - Botucatu - SP, February to May 1996.
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Table 3
Mean and Standard Error Mean of temperature eC), heart rate (beats per minute), mean arterial blood pressure - MABP (mmHg), blood
bicarbonate concentration (mEq/l), osmolality (mOsm), blood sodium (mmol/l), potassiurn (mmol/I), calcium (mg/dl) and glucose (mg/dI)
concentrations in dogs anaesthetised with methotrimeprazine, xylazine and ketarnine - MXK (n = 8) and methotrimeprazine, romifidine
and ketarnine - MRK (n = 8) - Botucatu - SP, February to May 1996.
before O 15 30 45 60 75
Minutes
Table 2
Mean and Standard Error Mean (minutes) of onset of action,
duration of surgery, duration of anaesthesia and time to assume
sternal and standing position of dogs anaesthetised with
methotrimeprazine/xylazinelketamine and methotrimeprazine/
romifidinelketamine and submitted to ovariohysterectomy -
Botucatu - SP, February to May 1996.
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t difference between groups (p < 0.05).
90 105 120
Temperature MXK 39.2±O.14 38.6±O.14 38.0±0.23* 37A±O.25* 37.0±O.25* 36.5±O.2* 36.0±O.17*
MRK 38.8±O.11 38A±O.18 37.8±O.22 37.3±O.25* 37.0±O.31* 36.7±O.35* 36. 5±O.39*
MXK 104±6 89±8 72±7* 65±7* 67±7* 67±6* 68±6*
MRK 109±10 89±6 83±11 81±9 81±12 78±13 66±10*
MXK 108±4 91±8 101±10 96±7 101±7 101±2 92±3
MRK 108±8 88±5 97±11 95±14 92±15 98±11 97±10
Bicarbonate MXK 19.8±1.0 20.9±1.0 19.9±1.2 20.3±1.2 19A±1.3 19.6±1.2 19.1±1.3
MRK 19.9±O.5 20.7±O.3 21.1±1.3 21A±1.2 20.9±1.4 21.1±1.5 21.0±1.5
MXK 282±1 284±1 286±1 286±2 286±2 286±2 284±4
MRK 281±3 283±2 283±3 286±1 286±1 285±3 286±3
MXK 141±1 145±1 145±1 146±1 145±1 145±1 144±1
MRK 143±2 144±1 144±1 145±1 145±1 144±1 144±1
MXK 3.86±O.16 3.76±O.17 3A6±O.12* 3.64±O.11 3.55±O.12 3.56±O.13 3.51±O.09
MRK 4.13±O.13 3.83±O.15 3.79±O.21 3.80±O.12 3.86±O.15 3.71±O.16 3.67±O.15*
MXK 3.32±OAO 3.81±O.22 3.25±O.26 4.15±O.15 3.85±OA5 3.65±O.39 3.79±O.32
MRK 3.58±0.26 3.97±0.24 3.84±OA1 4.04±OA 3.97±O.27 4.09±O.34 3.60±O.30
MXK 100±3 106±4 111±12 110±6 118±10 130±14 134±15
MRK 111±6 117±6 99±10 115±5 120±6 121±10 125±11
heart rate
MABP
Osmolality
Sodium
-
Potassium
Calcium
glucose
35.6±O.12*
36.0±OAO*
65±6*
67±10*
80±2*
94±9
18A±1.7
21.5±1.5
284±4
287±3
144±2
144±1
3.38±O.08*
3.61±O.13*
3.35±OA7
3.72±O.23
134±18
132±14
74±4*
35.8±OA3* 34.9±O.27*
62±8* 58±6*
81±6
* difference from basal values (before) in each group (p < 0.05). There was no difference between groups.
DISCUSSION
Like in horses, recovery from anaesthesia was longer
in dogs treated with romifidine/lcetamine when compared
to xylazine/ketamine in both anaesthetic and surgical
groups', Although not significant, the duration of anaesthesia
was also slightly longer after romifidine/lcetamine compared
with xylazine/lcetamine. Romifidine combined with ketarnine
also prolonged the time of recumbence when compared to
the use of romifidine alone'. It is important to mention that
recovery was longer in the surgi cal cases, showing that
trauma inflicted by surgery may prolong recovery. Although
recovery was longer after romifidine/lcetamine, the longer
duration of anaesthesia might be a potential advantage of
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romifidine, which should be considered.
The occurrence of myoclonia, shivering and muscle
spasm is a common fmding when ketamine is used 12 and
apparently xylazine produced a better muscle relaxation than
romifidine. This was a similar response than that observed in
horses, where romifidine produced less ataxia than xylazine'.
Hypotherrnia is a common finding during anaesthesia
and the causes have been discussed elsewhere-".
Reduction of the heart rate, atrioventricular block and
hypotension are usually observed after the use of a-Z
adrenoceptor agonists". The concomitant use of ketamine
probably delayed the arterial hypotension, which was observed
only at the end of anaesthesia':". The use of methotrimeprazine
probably also abolished the incidence of atrioventricular block
LUNA, S.P.L.; NOGUEIRA, C.S.; CRUZ, M.L.; MASSONE, F; CASTRO, G.B. Romifidine or xylazine combined with ketamine in dogs
premedicated with methotrimeprazine. Braz. J. vet. Res. animo Sci., São Paulo, v. 37, n. 2, p. 93-98, 2000.
Table 4
Mean and Standard Error Mean of respiratory rate (breaths/minute), tidal volume/kg (ml), minute volume/kg (rnl), pH, Pa02 (mmHg),
PaC02 (nunHg), expired CO2 (nunHg) and haemoglobin 02 saturation (%) in dogs anaesthetised with methotrimeprazine, xylazine and
ketamine - MXK (n = 8) and methotrimeprazine, rornifidine and ketamine - MRK (n = 8) - Botucatu - SP, February to May 1996.
before O 15 30 45 60 75 90 105 120
MXK 21±2 13±1 15±1 17±3 22±3 15±1 13±1 10±1*
MRK 21±2 15±1 13±1* 13±1* 16±2 14±3 13±2* 12±2*
MXK 21.7±1.4 18.9±1.2 13.5±0.8* 15.0±1.8* 14.5±1.9* 15.4±1.8* 16.6±1.4 16.8±1.6
MRK 19.8±2.1 19.9±2.7 12.9±2.0 13.9±1.7 14.0±2.4 14.9±2.4 17.3±2.5 17.7±1.6 18.1±1.7 18.0±1.4
MXK 444±36 240±18* 199±15* 233±26* 285±39* 261±52* 245±54* 158±9*
MRK 400±57 321±56 166±20* 184±14* 212±17* 202±30* 223±34* 219±28* 165±17* 132±11*
MXK 7.43±0.01 7.42±0.01 7.40±0.01 7.40±0.02 7.43±0.01 7.42±0.01 7.45±0.01 7.44±0.02
MRK 7.43±0.02 7.44±0.01 7.39±0.02 7.40±0.02 7.42±0.02 7.41±0.02 7.42±0.02 7.41±0.01
MXK 89.1±2.3 88.1±1.5 95.2±4.6 97.6±2.9 101.1±5.0 100.7±6.6 105.0±5.0* 107.4±3.9*
MRK 87.1±4.2 93.0±3.6 87.7±2.7 96.0±4.0 100.0±6.1 98.2±6.6 103.4±7.1 97.6±5.6
MXK 30.1±1.1 31.4±1.0 31.8±1.5 31.7±1.6 29.2±1.7 29.7±1.9 28.4±1.7 27.5±3.1
MRK 30.1±0.5 30.6±0.6 34.8±1.8 34.5±1.9 31.9±2.1 33.0±2.2 31.9±1.7 33.4±2.2
MXK 38.6±0.8 37.8±0.9 40.6±1.9 38.3±1.9 34.5±1.6t 32.5±2.3t 32.3±2.1 33.3±2.4
Expired C02 MRK 42.4±2.1 37.8±0.8 45.1±1.6 43.0±1.5 39.5±1.2t 39.0±1.6t 36.8±1.3* 37.5±0.8
02 saturation MXK 97.2±0.2 97.1±0.12 97.3±0.39 97.6±0.3 97.9±0.4 98.2±0.2 98.5±0.1* 98.4±0.2*t
MRK 96.8+0.5 97.6±0.2 96.5+0.4 97.4+0.2 97.6+0:5 97.7+0.3 97.9+0.3 97.3+0.3t
respiratory
rate
lidal
volume/kg
Minute
vol./kg
PH
10±1* 11±3*
* difference from basal values (before) in each group and t differences between groups (p < 0.05)
in dogs treated with xylazine/ketamine and minimised this
fmding in those dogs treated with romifidine/ketamine'.
Although respiratory rate and minute volume
decreased in both groups, these changes did not produce
respiratory acidosis as reported in a previous study, when
xylazine/ketamine was used in dogs'. The differences in Pa02,
haemoglobin 02 saturation and blood potassium
concentration in time in the two groups and the differences
in expired CO2 between the groups were minimal and did
not have biological importance, as the values were within
the normal range for the canine species.
Both anaesthetic techniques produced stable
cardiorespiratory function and can be considered safe when
this aspect is considered. Otherwise, quality of surgical
anaesthesia was not ideal, as some dogs showed increased
muscular tonus and also needed additional doses of the
combination and even local anaesthesia at the ovarian pedicle.
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RESUMO
Investigaram-se neste estudo os efeitos cardiorrespiratório e analgésico da associação de romifidina ou xilazina com a
quetamina em cães. Dezesseis cães receberam como medicação pré-anestésica 1,0 mg!kg de levomepromazina IV, seguido
de 0,1 mg!kg de romifidina (n = 8) ou 1,0 mg!kg de xilazina (n = 8) associadas a 15 mg!kg de quetamina 1M, utilizando-se
protocolo aleatório de seleção dos grupos, em estudo duplo cego. Os cães de ambos os grupos apresentaram hipoterrnia,
bradicardia, leve hipotensão e redução da freqüência respiratória e volume minuto. Poucas alterações foram observadas na
concentração de CO2 expirada e na saturação de 02 na hemoglobina. Os valores de pH, Pa02 e bioquímica sangüínea não
apresentaram diferenças ao longo do tempo em cada grupo ou entre os grupos. Os reflexos dolorosos permaneceram reduzidos
por até 30 a 45 minutos após a aplicação dos a-2 agonistas e quetamina. Doze cadelas foram divididas em dois grupos,
anestesiadas como acima e foram submetidas a ovarioisterectomia. A recuperação foi mais longa nas cadelas tratadas com
romifidina/quetarnina. Embora estes protocolos anestésicos tenham produzido mínimas alterações cardiorrespiratórias, a
qualidade da anestesia não foi ideal para ovarioisterectomia.
UNITERMOS: Metotrimepazina; Xilazina; Ketarnina; Cão.
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